Hildred Capital

Investor type

PE / VC

Founded

2018

AUM

$2 500 M

Location

New York City, New York, United States

$10-50 m

Investment Ticket

3-5 years

Investment Horizon

Series B, Late Stage (Series C+)

Investment Stage

IPO, M&A, Recapitalization, MBO

Exit Strategy

Investor profile last updated: 27 July, 2026

Profile

Hildred Capital is a New York based private equity firm focusing on the healthcare industry. Hildred pursues growth equity investments in lower middle market healthcare companies located in the U.S. and Canada with leading products, technologies and services. Hildred seeks opportunities to create value in healthcare companies with revenues of up to $100 million, from scaling businesses to generate earnings growth, promoting strategic and operational improvements, generating business development, and driving multiple expansion.

Industry

Financial Services Fintech Healthcare Services HealthTech Biotechnology Medical Devices Life Sciences

Region of investment

North America Europe

Hildred Capital Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Hildred Equity Partners III
Private Equity (PE)
Biotechnology
Healthcare Services
Medical Devices
Life Sciences
Series B
Late Stage (Series C+)
North America
$5-10 m
$800 M
January 2025
Hildred Equity Partners II
Private Equity (PE)
Biotechnology
Healthcare Services
Medical Devices
Life Sciences
Series B
Late Stage (Series C+)
North America
$5-10 m
$363 M
February 2022

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
sL72W8zQ6yFrxhYb sL72W8zQ6yFrxhYb
sL72W8zQ6yFrxhYb
avatar
sL72W8zQ6yFrxhYb sL72W8zQ6yFrxhYb
sL72W8zQ6yFrxhYb
avatar
sL72W8zQ6yFrxhYb sL72W8zQ6yFrxhYb
sL72W8zQ6yFrxhYb
avatar
sL72W8zQ6yFrxhYb sL72W8zQ6yFrxhYb
sL72W8zQ6yFrxhYb
avatar
sL72W8zQ6yFrxhYb sL72W8zQ6yFrxhYb
sL72W8zQ6yFrxhYb
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!

FAQs about Hildred Capital

Hildred Capital is located in New York City, New York, United States.
Hildred Capital was founded in 2018.
Hildred Capital invests in companies and startups in Financial Services, Fintech, Healthcare Services, HealthTech, Biotechnology, Medical Devices, Life Sciences.
Hildred Capital invests in companies and startups in North America, Europe.
Hildred Capital invests in companies and startups at Series B, Late Stage (Series C+).
Hildred Capital usually invests $10-50 m on average.
Hildred Capital has around $2 500m assets under management.
Hildred Capital last fund was created/launched in 2025-01-13